Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-21-000197

Chief Commercial Officer gave up 2,161 shares (to pay taxes)

  • Chief Commercial Officer acquired 7,337 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Rizvi Qasim · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-31 Exercise or conversion : show line 1 in the form +7,337 7,337 D
2020-12-31 Shares withheld for taxes : show line 2 in the form −2,161 $17.67 $38,185 5,176 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-31 Exercise or conversion : show line 3 in the form Restricted Share Unit −7,337 0 D
Loading xslF345X03/edgar.xml…